跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMLESSA TABLETS 8 mg/ 10 mg - HSA Drug Approval Details
Approvals
/
HSA
/
AMLESSA TABLETS 8 mg/ 10 mg
Approved
THERAPEUTIC
AMLESSA TABLETS 8 mg/ 10 mg
Krka, d.d., Novo mesto
🇸🇬 Health Sciences Authority
Approval Date
Jun 27, 2019
Approval ID
c4738f7ca2e17975
Company
Krka, d.d., Novo mesto
Type
Therapeutic
Approval Details
Approval Id
c4738f7ca2e17975
Drug Name
AMLESSA TABLETS 8 mg/ 10 mg
Product Name
AMLESSA TABLETS 8 mg/ 10 mg
Approval Number
SIN15726P
Approval Date
2019-06-27
Registrant
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C09BB04
Atc Item Name
perindopril and amlodipine
Pharma Manufacturer Name
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Company Detail Path
/organization/singapore-pharmaceutical-private-limited
Active Ingredients
Perindopril 6.68 mg eqv. to Perindopril tert-Butylamine
8.00 mg
Amlodipine besilate 13.870 mg eqv. to amlodipine
10.0mg
AMLODIPINE BESILATE 13.87 MG EQV. TO AMLODIPINE
10 MG
PERINDOPRIL 6.68 MG EQV. TO PERINDOPRIL TERT-BUTYLAMINE
8 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 27, 2019
Approval ID
c4738f7ca2e17975
Type
Therapeutic
Back to HSA Approvals
